{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:06:30Z","timestamp":1772777190303,"version":"3.50.1"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The treatment of COVID-19 in the post-transplant individuals is challenging, primarily due to the drug-drug interaction between nirmatrelvir\/ritonavir and tacrolimus. Deuremidevir hydrobromide tablets (VV116) is an orally small molecule agents target SARS-CoV-2 RdRp and inhibits viral replication. It may have a low likelihood of drug-drug interactions and has a potential to provide new treatment option. We described three cases of renal transplant patients with concomitant impaired renal function who developed COVID-19 pneumonia and were treated with VV116. Despite varying degrees of drug accumulation, these patients achieved rapid viral clearance and showed prompt improvement in pneumonia symptoms. Notably, tacrolimus blood concentrations remained within the therapeutic range throughout treatment, and no clinically significant adverse events were observed despite the drug accumulation.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1501813","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T06:52:51Z","timestamp":1737096771000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Severe metabolic accumulation of VV116 in kidney transplant patients with impaired renal function: a case series report"],"prefix":"10.3389","volume":"15","author":[{"given":"Jiaying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyun","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongkai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingmei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuorui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danlei","family":"Mou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianchun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.01.001","article-title":"Special considerations for paxlovid treatment among transplant recipients with Sars-Cov-2 infection","volume":"79","author":"Fishbane","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00009-4","article-title":"Pharmacological innovation and clinical value of vv116","volume":"24","author":"Jiang","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/03000605231177187","article-title":"Oximetry at Admission as a Predictor of Tomographic and Functional Impairment after 3-6 Months in Hospitalized Patients with Covid-19","volume":"51","author":"Villar","year":"2023","journal-title":"J Int Med Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221149292","article-title":"Clinical observation of glucocorticoid therapy for critically ill patients with Covid-19 pneumonia","volume":"51","author":"Zhu","year":"2023","journal-title":"J Int Med Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/v15122295","article-title":"Remdesivir derivative vv116 is a potential broad-spectrum inhibitor of both human and animal coronaviruses","volume":"15","author":"Liu","year":"2023","journal-title":"Viruses"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16636","article-title":"Long-term shedding of viable Sars-Cov-2 in kidney transplant recipients with Covid-19","volume":"21","author":"Benotmane","year":"2021","journal-title":"Am J Transplant"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.12.050","article-title":"Persistent replication of Sars-Cov-2 in a severely immunocompromised patient treated with several courses of remdesivir","volume":"104","author":"Camprub\u00ed","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1185278","article-title":"Sars-Cov-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the rivalsa prospective cohort","volume":"14","author":"Rizzi","year":"2023","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2136535","article-title":"Omicron infections profile and vaccination status among 1881 liver transplant recipients: A multi-centre retrospective cohort","volume":"11","author":"Ma","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1207225","article-title":"Omicron related Covid-19 prevention and treatment measures for patients with hematological Malignancy and strategies for modifying hematologic treatment regimes","volume":"13","author":"Guo","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1390705","article-title":"Repurposing the open global health library for the discovery of novel mpro destabilizers with scope as broad-spectrum antivirals","volume":"15","author":"Castillo","year":"2024","journal-title":"Front Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.08.026","article-title":"Safety, efficacy, and relapse of nirmatrelvir-ritonavir in kidney transplant recipients infected with Sars-Cov-2","volume":"7","author":"Devresse","year":"2022","journal-title":"Kidney Int Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytad193","article-title":"Case report: tacrolimus toxicity in the setting of concurrent paxlovid use in a heart-transplant recipient","volume":"7","author":"Modi","year":"2023","journal-title":"Eur Heart J Case Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2023.04.028","article-title":"Potential effects of remdesivir on tacrolimus exposure in transplant recipients with Covid-19 infection","volume":"8","author":"Habeeb","year":"2023","journal-title":"Kidney Int Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-01050-w","article-title":"Pharmacovigilance of drug-drug interactions with nirmatrelvir\/ritonavir","volume":"13","author":"Hendrick","year":"2024","journal-title":"Infect Dis Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-022-00895-6","article-title":"Safety, tolerability, and pharmacokinetics of vv116, an oral nucleoside analog against Sars-Cov-2, in chinese healthy subjects","volume":"43","author":"Qian","year":"2022","journal-title":"Acta Pharmacol Sin"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1501813\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T06:52:53Z","timestamp":1737096773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1501813\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":16,"alternative-id":["10.3389\/fimmu.2024.1501813"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1501813","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"article-number":"1501813"}}